Drug Trial Radar · NCT02472769
IBP-9414 for the Prevention of Necrotizing Enterocolitis
Last checked: Nov 20, 2026Latest source record: Dec 29, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Actual
Start
May 27, 2016
Primary completion
Aug 7, 2017
Study completion Aug 7, 2017
Sponsor
- Lead sponsor
- Infant Bacterial TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jun 16, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, up to 48 hours
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Two different dose levels will be evaluated in two different birth weight categories, compared to placebo with regards to safety and tolerability.
Conditions
- Necrotizing Enterocolitis
Interventions
IBP-9414Drug
PlaceboDrug
Sterile water
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and Tolerability of IBP-9414 as the observed number of adverse events (AE) and serious adverse events (SAE)Time frame: 12 months
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Univ. Arkansas Medical Sciences
Little Rock, Arkansas
UCLA Medical Center
Los Angeles, California
University Florida Health
Gainesville, Florida
Wolfson Children´s Hospital
Jacksonville, Florida
UF Health Jacksonville
Jacksonville, Florida
Jackson Memorial Hospital
Miami, Florida
Memorial Hospital of South Bend
South Bend, Indiana
Wesley Medical Center
Wichita, Kansas
Kings County Hospital Center
Brooklyn, New York
Duke University Medical Center
Durham, North Carolina
Wake Forest University Health Sciences
Winston-Salem, North Carolina
Hahnemann University Hospital
Philadelphia, Pennsylvania
Einstein Medical Center of Philadelphia
Philadelphia, Pennsylvania
Jackson Madison County General Hospital
Jackson, Tennessee
Timpanogos Regional Hospital
Orem, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.